NM_000085.5(CLCNKB):c.619del (p.Val207fs)Pathogenic
Bartter disease type 3|not provided
★★☆☆2026→ Residue 207
NM_000085.5(CLCNKB):c.610G>A (p.Ala204Thr)Pathogenic
Bartter disease type 3|not provided|Bartter disease type 4B;Bartter disease type 3|Bartter syndrome
★★☆☆2025→ Residue 204
NM_000085.5(CLCNKB):c.1172G>A (p.Trp391Ter)Pathogenic
not provided
★★☆☆2025→ Residue 391
NM_000085.5(CLCNKB):c.968+1G>APathogenic
not provided|Bartter disease type 3;Bartter disease type 4B|Nonpapillary renal cell carcinoma|Autosomal recessive CLCNKB-related disorders
★★☆☆2025
NM_000085.5(CLCNKB):c.1897del (p.Thr632_Leu633insTer)Pathogenic
Bartter disease type 3|Bartter disease type 3;Bartter disease type 4B|not provided
★★☆☆2025→ Residue 632
NM_000085.5(CLCNKB):c.1830G>A (p.Trp610Ter)Pathogenic
Bartter syndrome, type 3, with hypocalciuria|not provided|Bartter disease type 4B;Bartter disease type 3|Bartter disease type 3
★★☆☆2025→ Residue 610
NM_000085.5(CLCNKB):c.229G>C (p.Ala77Pro)Pathogenic
not provided|Bartter syndrome
★★☆☆2025→ Residue 77
NM_000085.5(CLCNKB):c.1309G>A (p.Gly437Arg)Pathogenic
Bartter disease type 3|Bartter disease type 3;Bartter disease type 4B|not provided|Bartter syndrome
★★☆☆2025→ Residue 437
NM_000085.5(CLCNKB):c.1270G>A (p.Gly424Arg)Likely pathogenic
Bartter disease type 3|Bartter disease type 4B;Bartter disease type 3|not provided
★★☆☆2025→ Residue 424
NM_000085.5(CLCNKB):c.1312C>T (p.Arg438Cys)Pathogenic
Bartter disease type 3|not provided|Bartter disease type 4B;Bartter disease type 3
★★☆☆2025→ Residue 438
NM_000085.5(CLCNKB):c.1783C>T (p.Arg595Ter)Pathogenic
not provided|Bartter disease type 3|Bartter disease type 3;Bartter disease type 4B
★★☆☆2025→ Residue 595
NM_000085.5(CLCNKB):c.782-2A>GPathogenic
Bartter disease type 3|not provided|Bartter disease type 4B;Bartter disease type 3
★★☆☆2025
NM_000085.5(CLCNKB):c.73del (p.Cys25fs)Pathogenic
not provided|Bartter disease type 3
★★☆☆2025→ Residue 25
NM_000085.5(CLCNKB):c.508G>A (p.Val170Met)Pathogenic
not provided|Bartter disease type 4B;Bartter disease type 3
★★☆☆2024→ Residue 170
NM_000085.5(CLCNKB):c.1313G>A (p.Arg438His)Pathogenic
not provided|Bartter syndrome|Bartter disease type 3;Bartter disease type 4B
★★☆☆2024→ Residue 438
NM_000085.5(CLCNKB):c.910C>T (p.Arg304Ter)Pathogenic
Bartter disease type 3|not provided|Bartter disease type 3;Bartter disease type 4B|Autosomal dominant osteopetrosis 1
★★☆☆2024→ Residue 304
NM_000085.5(CLCNKB):c.937_940dup (p.Arg314delinsLysTer)Pathogenic
Hematuria;Proteinuria|Bartter disease type 3|not provided
★★☆☆2024→ Residue 314
NM_000085.5(CLCNKB):c.18dup (p.Leu7fs)Pathogenic
not provided|Bartter disease type 3|Bartter disease type 3;Bartter disease type 4B
★★☆☆2024→ Residue 7
NM_000085.5(CLCNKB):c.1325A>G (p.Glu442Gly)Pathogenic
not provided|Bartter disease type 3|Bartter syndrome|Bartter disease type 4B;Bartter disease type 3
★★☆☆2024→ Residue 442
NM_000085.5(CLCNKB):c.36del (p.Asn14fs)Pathogenic
not provided|Bartter disease type 4B;Bartter disease type 3
★★☆☆2024→ Residue 14